ImmunOs Therapeutics
ID: 7645285Immune system-modulating technology platform for the treatment of cancer and autoimmune diseases.
7
Funding Rounds
$210.5m
Money raised
Recent Funding Rounds
Overview
Immune system-modulating technology platform for the treatment of cancer and autoimmune diseases.
- Website:
- Business model: B2B
- Headquarters: Zürich
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company ImmunOs Therapeutics has raised a total of $210.5m in funding over 7 rounds.
Key Insights:
- ImmunOs Therapeutics Series C Round, September 2024: $11m
- ImmunOs Therapeutics Series B round, June 2022: $74m
- ImmunOs Therapeutics June 2022 Funding Round: $74m
- ImmunOs Therapeutics December 2019 Series A Funding Round: $17m
- ImmunOs Therapeutics December 2019 Series A Funding Round: $17m
- ImmunOs Therapeutics Series A round, December 2019: $15m
- ImmunOs Therapeutics December 2017 Seed Funding Round: $2.5m
Industries
ImmunOs Therapeutics is active in the following industries: